Kaelgemvax received European patent of malaria vaccine

Published: 2014-05-27 15:25:12

Updated: 2014-05-27 15:25:12

Domestic biotech company Kaelgemvax, announced that they received European patent of malaria vaccine. This patent will be notified on June 4, 2014 to the European Patent Office (EPO). (Patent Number: EP1, 569,950)

This malaria vaccine patent is for the treatment and prevention of malaria induced by plasmodium falciparum, and it received U.S. patent on September, 2011.

The company explained th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.